We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $174B
1-Year Est. Return 30.96%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
+6.87%
1 Year Est. Return
+30.96%
3 Year Est. Return
+104.8%
5 Year Est. Return
+143.7%
10 Year Est. Return
+536.36%
AUM
$80.4B
AUM Growth
+$16.9B
Cap. Flow
+$13.1B
Cap. Flow %
16.25%
Top 10 Hldgs %
16.5%
Holding
2,570
New
6
Increased
1,330
Reduced
128
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$506M
2
MSFT icon
Microsoft
MSFT
+$355M
3
XOM icon
ExxonMobil
XOM
+$267M
4
AMZN icon
Amazon
AMZN
+$257M
5
META icon
Meta Platforms (Facebook)
META
+$245M

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Healthcare 15%
3 Consumer Discretionary 10.63%
4 Communication Services 10.48%
5 Industrials 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLGEA icon
2476
Village Super Market
VLGEA
$639M
$321K ﹤0.01%
12,100
+1,800
+17% +$52.3K
ZVO
2477
DELISTED
Zovio Inc. Common Stock
ZVO
$320K ﹤0.01%
30,000
WVE icon
2478
Wave Life Sciences
WVE
$1.2B
$316K ﹤0.01%
11,500
CGI
2479
DELISTED
Celadon Group Inc
CGI
$316K ﹤0.01%
48,300
RT
2480
DELISTED
Ruby Tuesday Georgia
RT
$316K ﹤0.01%
112,500
ATEX icon
2481
Anterix
ATEX
$1.94B
$309K ﹤0.01%
14,150
+2,300
+19% +$52K
OMED
2482
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$306K ﹤0.01%
33,200
+6,000
+22% +$52.7K
COLL icon
2483
Collegium Pharmaceutical
COLL
$956M
$305K ﹤0.01%
30,300
NRC icon
2484
NRC Health Common Stock
NRC
$450M
$305K ﹤0.01%
15,500
+2,600
+20% +$48.1K
LIND icon
2485
Lindblad Expeditions
LIND
$2.22B
$304K ﹤0.01%
33,941
HOME
2486
DELISTED
At Home Group Inc.
HOME
$302K ﹤0.01%
19,900
SRNE
2487
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$299K ﹤0.01%
75,764
CIE
2488
DELISTED
Cobalt International Energy, Inc
CIE
$296K ﹤0.01%
36,938
NTLA icon
2489
Intellia Therapeutics
NTLA
$1.67B
$292K ﹤0.01%
20,700
USLM icon
2490
United States Lime & Minerals
USLM
$3.44B
$292K ﹤0.01%
18,500
+3,000
+19% +$45.8K
WEYS icon
2491
Weyco Group
WEYS
$440M
$292K ﹤0.01%
10,400
+1,600
+18% +$45K
CONN
2492
DELISTED
Conn's Inc.
CONN
$284K ﹤0.01%
32,400
BCOM
2493
DELISTED
B Communications Ltd
BCOM
$284K ﹤0.01%
14,148
AC
2494
DELISTED
Associated Capital Group
AC
$278K ﹤0.01%
7,739
+1,508
+24% +$54.7K
DGICA icon
2495
Donegal Group Class A
DGICA
$714M
$275K ﹤0.01%
15,600
+2,100
+16% +$35.6K
CRD.A icon
2496
Crawford & Co Class A
CRD.A
$669M
$269K ﹤0.01%
33,038
MCRB icon
2497
Seres Therapeutics
MCRB
$48.9M
$267K ﹤0.01%
1,185
ONDK
2498
DELISTED
On Deck Capital, Inc.
ONDK
$264K ﹤0.01%
52,400
ENT
2499
DELISTED
Global Eagle Entertainment Inc.
ENT
$263K ﹤0.01%
3,304
+264
+9% +$34.4K
GBL
2500
DELISTED
GAMCO Investors, Inc.
GBL
$253K ﹤0.01%
8,543

Similar funds

Swiss National Bank's Q1 2017 Portfolio in Review

As of Q1 2017, Swiss National Bank held 2,570 positions worth $80.4B, up 27% from $63.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Swiss National Bank deployed $13.1B of net new capital in Q1 2017, opening 6 new positions and adding to 1,330 existing holdings. Its largest new stake was Qiagen: 988,583 shares worth $30.5M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Canadian National Railway, an estimated $86.2M trimmed.

  • Swiss National Bank's largest Q1 2017 buy was Qiagen: 988,583 shares worth $30.5M.
  • Swiss National Bank added most to Apple in Q1 2017, an estimated $506M increase.
  • Swiss National Bank's biggest Q1 2017 reduction was Canadian National Railway, cutting an estimated $86.2M.
  • Swiss National Bank fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $79.6M.
  • Swiss National Bank's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2017.
  • Swiss National Bank opened 6 new positions and closed 36 in Q1 2017.
  • Swiss National Bank's portfolio value rose 27% quarter-over-quarter to $80.4B.

Based on Swiss National Bank's 13F filing for Q1 2017, filed 4 May 2017.